Contact
Biography
Dr. Charlotte Hall completed her PhD in Forensic and Cognitive Psychology at the University of Lincoln in 2011. Her PhD investigated the potential use of gaze patterns as a measure of detecting sexual preference in forensic populations. Prior to this Charlotte worked as a research assistant on a number of projects, investigating diverse topics including psycholinguistics, child development, emotion, comparative cognition and forensic mental health.
Charlotte joined the University of Nottingham through the NIHR- Collaborations for Leadership in Applied Health Research and Care (CLAHRC-NDL) in November 2011, as a Research Fellow investigating the use of routine outcome measures in mental health services, the transition process and service provision for young people with ADHD leaving child and adolescent mental health services, and medication management for young people with ADHD. In 2014 Charlotte took up the position of lead Research Fellow on the AQUA-Trial, a multi-site randomised control trial investigating the clinical utility and economic cost of the QbTest (a continuous performance test) in aiding the diagnostic and medication management process in ADHD. The trial was funded by NIHR-CLAHRC-EM.
In her current role, Charlotte is Trial Manager on the NIHR HTA 'ORBIT' (Online Remote Behavioral Intervention for Tics) RCT. The ORBIT trial aims to evaluate the clinical and cost -effectiveness of BiP TIC: a therapist-guided, parent-assisted iCBT (internet-based cognitive behavioural therapy) intervention programme for tics in young people with Tourette Syndrome (TS), compared with usual care plus online education.
Charlotte is also a co-investigator on the QUOTA-study funded by the NIHR- Research for Patient Benefit (RfPB). The aim of the QUOTA study are to develop a standardised QbTest medication management protocol and to measure its feasibility and acceptability in a feasibility RCT.
Expertise Summary
Keywords:
ADHD
Continuous Performance Tests (CPT)
QbTest
Outcome measures
Randomised controlled trials
Research Summary
Charlotte is currently Trial Manager on the ORBIT-Trial. The aim of this study is to assess the clinical and cost-effectiveness of a remotely delivered therapist guided, parent assisted digital… read more
Selected Publications
HALL, C.L., MOLDAVSKY, M., TAYLOR, J., SAYAL, K., MARRIOT, M., BATTY, M., PASS, S. and HOLLIS, C., 2014. Implementation of routine outcome measurement in Child and Adolescent Mental Health Services in the United Kingdom: a critical perspective. European Child & Adolescent Psychiatry. 23(4), 239-242 HALL, C.L., NEWELL, K., TAYLOR, J., SAYAL, K., SWIFT, K.D. and HOLLIS, C., 2013. 'Mind the gap' - Mapping services for young people with ADHD transitioning from child to adult mental health services. BMC Psychiatry. 13, 186 SWIFT, K.D., HALL, C.L., MARIMUTTU, V.J., REDSTONE, L., SAYAL, K. and HOLLIS, C., 2013. Transition to adult mental health services for young people with Attention Deficit/Hyperactivity Disorder (ADHD): A qualitative analysis of their experiences. BMC Psychiatry. 13, 74 HALL, C.L, HOGUE, T and GUO, K, 2012. Sexual cognitions guide viewing strategies to human figures Journal of Sex Research.
Current Research
Charlotte is currently Trial Manager on the ORBIT-Trial. The aim of this study is to assess the clinical and cost-effectiveness of a remotely delivered therapist guided, parent assisted digital behavioural intervention (BiP TIC) for treating moderate and severe tics in children and adolescents with Tourette syndrome (TS) or chronic tic disorder (CTD). The trial is a single-blind parallel-group randomised, controlled, superiority trial of treatment as usual (TAU) + remote therapist-guided digital behavioural intervention (BiP TIC) compared to active control (TAU + remote online education and therapist support without BiP TIC), in children and young people (aged 9-17) with TS or CTD. The trial is recruiting nationally from CAMHS and community paediatrics, via the national charity Tourettes Action and from specialist Tourette's clinics in England. The intervention isbe delivered remotely from 2 regional centres in the Midlands/North (Queen's Medical Centre, Nottingham) and South of England (Great Ormond Street Hospital, London). There will be an initial internal pilot with strict 'stop-go' progression criteria to determine the acceptability of randomisation, adherence with the digital intervention and retention to follow-up.
Charlotte is also a co-investigator on the QUOTA study, which looks at the potential utility of a computerized cognitive test for ADHD, QbTest, to determine whether it can be a useful aid to medication management in ADHD
Charlotte also maintains her interest in general in investigating more objective measures for use in routine mental health (clinical and forensic) settings, particularly through through the use of technology.
Past Research
My previous research extends across multiple disciplinary fields, but primarily lies in 'applied cognitive psychology'.
My PhD investigated the potential of gaze patterns as a measure to detect sexual preference. As part of this I was particularly interested in how gaze patterns may reflect previously reported differences in sexual arousal and interest in men and women. This research also investigated the link between subjective (i.e., self-report) and objective (gaze patterns) measures of sexual preference. Of primary interest to this research was the extent to which gaze patterns may be sensitive to deviant sexual preferences.
My previous post was lead researcher on the AQUA-Trial. The primary objective of this study is to assess whether providing clinicians and patients with the results of an objective test of activity and attention (QbTest) leads to earlier correct diagnosis of Attention Deficit/Hyperactivity Disorder (ADHD). A secondary objective is to assess whether the QbTest leads to earlier optimisation of treatment and improved patient outcomes in ADHD in routine NHS settings. Together these findings assessed whether the QbTest can improve practice and patient outcome for children with ADHD, as well as its feasibility and acceptability and cost-effectiveness when added to routine healthcare settings. The findings have been published.